US 8598364
Oligomer-protease inhibitor conjugates
granted A61KA61K47/60A61P
Quick answer
US patent 8598364 (Oligomer-protease inhibitor conjugates) held by Nektar Therapeutics expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K47/60, A61P, A61P31/12, A61P31/16